RhumbLine Advisers
TELA icon

RhumbLine Advisers’s TELA Bio TELA Stock Holding History

RhumbLine Advisers’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,499
Closed -$11.7K – 4326
2024
Q2 		$11.7K Sell
2,499
-12,596
-83% -$66.4K ﹤0.01% 3961
2024
Q1 		$85.6K Buy
15,095
+329
+2% +$2.17K ﹤0.01% 3482
2023
Q4 		$97.7K Buy
14,766
+178
+1% +$1.03K ﹤0.01% 3454
2023
Q3 		$117K Buy
14,588
+880
+6% +$8.18K ﹤0.01% 3412
2023
Q2 		$139K Buy
+13,708
New +$140K ﹤0.01% 3404

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

RhumbLine Advisers's TELA Position: Q3 2024 in Review

RhumbLine Advisers sold out of TELA Bio (TELA) in Q3 2024, closing a stake of 2,499 shares — an estimated $11.7K sold.

RhumbLine Advisers first reported a position in TELA in Q2 2023 and held it in 5 quarters. The position peaked at $139K in Q2 2023. 49 funds tracked by Wall St. Rank hold TELA as of Q3 2024.

  • RhumbLine Advisers reported no remaining TELA Bio position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 2,499 TELA Bio shares in Q3 2024, an estimated $11.7K.
  • RhumbLine Advisers first reported a position in TELA Bio in Q2 2023 and held it in 5 quarters.
  • RhumbLine Advisers's TELA Bio position peaked at $139K in Q2 2023.
  • 49 funds tracked by Wall St. Rank held TELA Bio as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.